Showing results (551-560 of 1,185) with videos related to

Sort By:
Pageof 119
Proceedings of the IEEE ... Annual Northeast Bioengineering Conference. IEEE Northeast Bioengineering Conference|July 21, 2015
Assessing Physical Performance in Free-Living Older Adults with a Wearable ComputerQi Zhao, Jingjing Wang, Wenquan Feng, et al.
European Journal of Vascular Surgery|May 1, 1993
Contralateral stenosis and stump pressures: parameters to identify the high risk patient undergoing carotid endarterectomy under local anaesthesiaP E Burke, E Prendiville, E Tadros, et al.
Obstetrics and Gynecology|January 1, 1996
Fetal hyperinsulinism at 14-20 weeks and subsequent gestational diabetesM W Carpenter, J A Canick, J Star, et al.
Thrombosis Research|May 1, 1991
Enhancement of the thrombolytic efficacy of prourokinase by lys-plasminogen in a dog model of arterial thrombosisS F Badylak, S L Voytik, J Henkin, et al.
European Journal of Cardiovascular Nursing|May 13, 2006
Evaluation of the shortened Cholesterol-Lowering Diet Self-Efficacy ScaleLora E Burke, Yookyung Kim, Fisun Senuzun, et al.
Frontiers in Psychology|April 20, 2017
Social Dominance Orientation, Dispositional Empathy, and Need for Cognitive Closure Moderate the Impact of Empathy-Skills Training, but Not Patient Contact, on Medical Students' Negative Attitudes toward Higher-Weight PatientsAngela Meadows, Suzanne Higgs, Sara E Burke, et al.
Family Process|August 7, 1998
Assessing individual family members' constructions of family problemsL Heatherington, M L Friedlander, B Johnson, et al.
Journal of Biomechanical Engineering|February 2, 2011
Wall shear stresses remain elevated in mature arteriovenous fistulas: a case studyG T Carroll, T M McGloughlin, P E Burke, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|August 20, 2009
Utilization of 3-month yoga program for adults at high risk for type 2 diabetes: a pilot studyKyeongra Yang, Lisa M Bernardo, Susan M Sereika, et al.
Contraception: X|June 19, 2020
A 1-year prospective, open-label, single-arm, multicenter, phase 3 trial of the contraceptive efficacy and safety of the oral progestin-only pill drospirenone 4 mg using a 24/4-day regimenThomas Kimble, Anne E Burke, Kurt T Barnhart, et al.
Pageof 119